Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FE966
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $158,159
Award facts
- Contract value 100% obligated
- $158,159.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $158,159.28 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 16, 2026, with an ultimate completion date of February 9, 2026. This competitively awarded, non-set-aside contract represents a child delivery order issued against a larger Indefinite Delivery Contract vehicle. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that supplies a comprehensive range of medical products to federal healthcare systems. The company's parent entity is Cencora, Inc. (doing business as Amerisourcebergen), which holds the primary $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical through December 2026, enabling supply of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military and veteran healthcare systems globally.
This delivery order exemplifies Amerisourcebergen's extensive role in the federal pharmaceutical supply chain, particularly supporting the Defense Health Agency and other military healthcare programs. The company's contract awards demonstrate consistent capability in delivering diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and critical medical supplies. The contract structure reflects DLA's strategy of utilizing experienced prime vendors through indefinite delivery vehicles to ensure reliable access to essential pharmaceuticals and medical commodities for military treatment facilities and other federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DU26FE966?
SPE2DU26FE966 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DU26FE966 worth?
The government has obligated $158,159 on SPE2DU26FE966.
Is contract SPE2DU26FE966 an order under another contract?
Yes. SPE2DU26FE966 is a delivery order under SPE2DU25D5117, an indefinite delivery contract.
Was contract SPE2DU26FE966 competed?
The extent of competition for SPE2DU26FE966 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award